Abeona Therapeutics
ABEO
ABEO
79 hedge funds and large institutions have $64.6M invested in Abeona Therapeutics in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
19% less funds holding
Funds holding: 98 → 79 (-19)
53% less capital invested
Capital invested by funds: $138M → $64.6M (-$73.9M)
68% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 28
Holders
79
Holding in Top 10
1
Calls
$802K
Puts
$220K
Top Buyers
| 1 | +$7.31M | |
| 2 | +$1.09M | |
| 3 | +$793K | |
| 4 |
Goldman Sachs
New York
|
+$381K |
| 5 |
D.E. Shaw & Co
New York
|
+$316K |
Top Sellers
| 1 | -$7.91M | |
| 2 | -$1.76M | |
| 3 | -$716K | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$471K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$387K |